{"transactions":[{"id":2649368,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2021-06-30T20:45:49.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":446,"price":365,"value":162790.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 26, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a sale event."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-21-000138","document":"wf-form4_162508592671674.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130821000138/wf-form4_162508592671674.xml","form_type":"4"}},{"id":2659927,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2021-06-21T20:43:42.000Z","date":"2021-06-18","kind":"sale","acquired":false,"shares":486,"price":325.8919,"value":158383.4634,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 17, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon a sale event."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-21-000125","document":"wf-form4_162430820122597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130821000125/wf-form4_162430820122597.xml","form_type":"4"}},{"id":2674995,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2021-06-09T20:48:21.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":650,"price":354.1577,"value":230202.505,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon a sale event."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.65 to $354.25, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-21-000109","document":"wf-form4_162327168180794.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130821000109/wf-form4_162327168180794.xml","form_type":"4"}},{"id":2903855,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-19T22:04:36.000Z","date":"2021-01-15","kind":"exercise","acquired":false,"shares":163800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These securities vest over a four-year period as follows: 25% on July 15, 2016, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon a sale event or certain termination events."}],"balance_after":649000,"derivative":{"exercise_price":0.5,"expiration_date":"2025-07-01","underlying":"Ordinary Shares","underlying_shares":163800},"source":{"system":"sec-edgar","filing":"0001651308-21-000011","document":"wf-form4_161109386344448.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130821000011/wf-form4_161109386344448.xml","form_type":"4"}},{"id":2903854,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-19T22:04:36.000Z","date":"2021-01-14","kind":"exercise","acquired":false,"shares":18200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These securities vest over a four-year period as follows: 25% on July 15, 2016, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon a sale event or certain termination events."}],"balance_after":812800,"derivative":{"exercise_price":0.5,"expiration_date":"2025-07-01","underlying":"Ordinary Shares","underlying_shares":18200},"source":{"system":"sec-edgar","filing":"0001651308-21-000011","document":"wf-form4_161109386344448.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130821000011/wf-form4_161109386344448.xml","form_type":"4"}},{"id":2903853,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2021-01-19T22:04:36.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":5606,"price":345.5382,"value":1937087.1492,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $345.30 to $345.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-21-000011","document":"wf-form4_161109386344448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130821000011/wf-form4_161109386344448.xml","form_type":"4"}},{"id":2903852,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2021-01-19T22:04:36.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":6994,"price":344.3812,"value":2408602.1128,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $344.00 to $344.97, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":5606,"source":{"system":"sec-edgar","filing":"0001651308-21-000011","document":"wf-form4_161109386344448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130821000011/wf-form4_161109386344448.xml","form_type":"4"}},{"id":2903851,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2021-01-19T22:04:36.000Z","date":"2021-01-15","kind":"exercise","acquired":true,"shares":12600,"price":6.5,"value":81900.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":12600,"source":{"system":"sec-edgar","filing":"0001651308-21-000011","document":"wf-form4_161109386344448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130821000011/wf-form4_161109386344448.xml","form_type":"4"}},{"id":2903850,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2021-01-19T22:04:36.000Z","date":"2021-01-14","kind":"sale","acquired":false,"shares":300,"price":345.1533,"value":103545.99,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $345.15 to $345.155, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-21-000011","document":"wf-form4_161109386344448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130821000011/wf-form4_161109386344448.xml","form_type":"4"}},{"id":2903849,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2021-01-19T22:04:36.000Z","date":"2021-01-14","kind":"sale","acquired":false,"shares":1100,"price":344.2818,"value":378709.98,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $344.11 to $344.455, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001651308-21-000011","document":"wf-form4_161109386344448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130821000011/wf-form4_161109386344448.xml","form_type":"4"}},{"id":2903848,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2021-01-19T22:04:36.000Z","date":"2021-01-14","kind":"exercise","acquired":true,"shares":1400,"price":6.5,"value":9100.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":1400,"source":{"system":"sec-edgar","filing":"0001651308-21-000011","document":"wf-form4_161109386344448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130821000011/wf-form4_161109386344448.xml","form_type":"4"}},{"id":2941839,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-16T21:43:50.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":2600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F12","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"These securities vest over a four-year period as follows: 25% on July 15, 2016, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon a sale event or certain termination events."}],"balance_after":831000,"derivative":{"exercise_price":0.5,"expiration_date":"2025-07-01","underlying":"Ordinary Shares","underlying_shares":2600000},"source":{"system":"sec-edgar","filing":"0001651308-20-000233","document":"wf-form4_160815501734729.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000233/wf-form4_160815501734729.xml","form_type":"4"}},{"id":2941838,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-12-16T21:43:50.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":700,"price":232.1886,"value":162532.02,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected solely to cover the exercise cost and satisfy tax obligations for the share options that were exercised."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.97 to $232.58, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-20-000233","document":"wf-form4_160815501734729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000233/wf-form4_160815501734729.xml","form_type":"4"}},{"id":2941837,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-12-16T21:43:50.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":17456,"price":231.1127,"value":4034303.2912,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected solely to cover the exercise cost and satisfy tax obligations for the share options that were exercised."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.89 to $231.87, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":700,"source":{"system":"sec-edgar","filing":"0001651308-20-000233","document":"wf-form4_160815501734729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000233/wf-form4_160815501734729.xml","form_type":"4"}},{"id":2941836,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-12-16T21:43:50.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":24842,"price":230.5066,"value":5726244.9572,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected solely to cover the exercise cost and satisfy tax obligations for the share options that were exercised."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.88 to $230.87, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":18156,"source":{"system":"sec-edgar","filing":"0001651308-20-000233","document":"wf-form4_160815501734729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000233/wf-form4_160815501734729.xml","form_type":"4"}},{"id":2941835,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-12-16T21:43:50.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":9752,"price":229.1799,"value":2234962.3848,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected solely to cover the exercise cost and satisfy tax obligations for the share options that were exercised."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.82 to $229.79, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":42998,"source":{"system":"sec-edgar","filing":"0001651308-20-000233","document":"wf-form4_160815501734729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000233/wf-form4_160815501734729.xml","form_type":"4"}},{"id":2941834,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-12-16T21:43:50.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":5885,"price":228.2288,"value":1343126.488,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected solely to cover the exercise cost and satisfy tax obligations for the share options that were exercised."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.80 to $228.795, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":52750,"source":{"system":"sec-edgar","filing":"0001651308-20-000233","document":"wf-form4_160815501734729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000233/wf-form4_160815501734729.xml","form_type":"4"}},{"id":2941833,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-12-16T21:43:50.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":400,"price":228.1,"value":91240.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected solely to cover the exercise cost and satisfy tax obligations for the share options that were exercised."}],"balance_after":58635,"source":{"system":"sec-edgar","filing":"0001651308-20-000233","document":"wf-form4_160815501734729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000233/wf-form4_160815501734729.xml","form_type":"4"}},{"id":2941832,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-12-16T21:43:50.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":7500,"price":227.7226,"value":1707919.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected solely to cover the exercise cost and satisfy tax obligations for the share options that were exercised."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.03 to $228.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":59035,"source":{"system":"sec-edgar","filing":"0001651308-20-000233","document":"wf-form4_160815501734729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000233/wf-form4_160815501734729.xml","form_type":"4"}},{"id":2941831,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-12-16T21:43:50.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":15062,"price":227.0793,"value":3420268.4166,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected solely to cover the exercise cost and satisfy tax obligations for the share options that were exercised."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.77 to $227.70, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":66535,"source":{"system":"sec-edgar","filing":"0001651308-20-000233","document":"wf-form4_160815501734729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000233/wf-form4_160815501734729.xml","form_type":"4"}},{"id":2941830,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-12-16T21:43:50.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":6203,"price":226.4029,"value":1404377.1887,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected solely to cover the exercise cost and satisfy tax obligations for the share options that were exercised."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.77 to $226.70, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":81597,"source":{"system":"sec-edgar","filing":"0001651308-20-000233","document":"wf-form4_160815501734729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000233/wf-form4_160815501734729.xml","form_type":"4"}},{"id":2941829,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-12-16T21:43:50.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":4100,"price":225.239,"value":923479.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected solely to cover the exercise cost and satisfy tax obligations for the share options that were exercised."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.75 to $225.74, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":87800,"source":{"system":"sec-edgar","filing":"0001651308-20-000233","document":"wf-form4_160815501734729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000233/wf-form4_160815501734729.xml","form_type":"4"}},{"id":2941828,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-12-16T21:43:50.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":91900,"price":6.5,"value":597350.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":91900,"source":{"system":"sec-edgar","filing":"0001651308-20-000233","document":"wf-form4_160815501734729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000233/wf-form4_160815501734729.xml","form_type":"4"}},{"id":2941827,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Ordinary Shares","published_at":"2020-12-16T21:43:50.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":1405300,"price":0.5,"value":702650.0,"ownership":{"direct":true},"balance_after":1573715,"source":{"system":"sec-edgar","filing":"0001651308-20-000233","document":"wf-form4_160815501734729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000233/wf-form4_160815501734729.xml","form_type":"4"}},{"id":3010572,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-07T20:50:09.000Z","date":"2020-10-05","kind":"exercise","acquired":false,"shares":182000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F13","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"These securities vest over a four-year period as follows: 25% on July 15, 2016, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon a sale event or certain termination events."}],"balance_after":3431000,"derivative":{"exercise_price":0.5,"expiration_date":"2025-07-01","underlying":"Ordinary Shares","underlying_shares":182000},"source":{"system":"sec-edgar","filing":"0001651308-20-000194","document":"wf-form4_160210368555324.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000194/wf-form4_160210368555324.xml","form_type":"4"}},{"id":3010571,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-10-07T20:50:09.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":300,"price":304.15,"value":91245.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-20-000194","document":"wf-form4_160210368555324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000194/wf-form4_160210368555324.xml","form_type":"4"}},{"id":3010570,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-10-07T20:50:09.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":1869,"price":303.2408,"value":566757.0552,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.70 to $303.52, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001651308-20-000194","document":"wf-form4_160210368555324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000194/wf-form4_160210368555324.xml","form_type":"4"}},{"id":3010569,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-10-07T20:50:09.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":2831,"price":302.1053,"value":855260.1043,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.65 to $302.59, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":2169,"source":{"system":"sec-edgar","filing":"0001651308-20-000194","document":"wf-form4_160210368555324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000194/wf-form4_160210368555324.xml","form_type":"4"}},{"id":3010568,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-10-07T20:50:09.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":1499,"price":300.8835,"value":451024.3665,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.64 to $301.29, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001651308-20-000194","document":"wf-form4_160210368555324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000194/wf-form4_160210368555324.xml","form_type":"4"}},{"id":3010567,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-10-07T20:50:09.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":2001,"price":300.0845,"value":600469.0845,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $299.64 to $300.63, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":6499,"source":{"system":"sec-edgar","filing":"0001651308-20-000194","document":"wf-form4_160210368555324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000194/wf-form4_160210368555324.xml","form_type":"4"}},{"id":3010566,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-10-07T20:50:09.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":1000,"price":298.966,"value":298966.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $298.45 to $299.13, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001651308-20-000194","document":"wf-form4_160210368555324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000194/wf-form4_160210368555324.xml","form_type":"4"}},{"id":3010565,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-10-07T20:50:09.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":1200,"price":297.9775,"value":357573.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $297.45 to $298.30, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":9500,"source":{"system":"sec-edgar","filing":"0001651308-20-000194","document":"wf-form4_160210368555324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000194/wf-form4_160210368555324.xml","form_type":"4"}},{"id":3010564,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-10-07T20:50:09.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":500,"price":296.474,"value":148237.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $296.36 to $296.90, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":10700,"source":{"system":"sec-edgar","filing":"0001651308-20-000194","document":"wf-form4_160210368555324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000194/wf-form4_160210368555324.xml","form_type":"4"}},{"id":3010563,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-10-07T20:50:09.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":568,"price":295.7268,"value":167972.8224,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $295.30 to $296.21, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":11200,"source":{"system":"sec-edgar","filing":"0001651308-20-000194","document":"wf-form4_160210368555324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000194/wf-form4_160210368555324.xml","form_type":"4"}},{"id":3010562,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-10-07T20:50:09.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":1415,"price":294.9212,"value":417313.498,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $294.27 to $295.24, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":11768,"source":{"system":"sec-edgar","filing":"0001651308-20-000194","document":"wf-form4_160210368555324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000194/wf-form4_160210368555324.xml","form_type":"4"}},{"id":3010561,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-10-07T20:50:09.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":817,"price":293.2626,"value":239595.5442,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.00 to $293.99, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":13183,"source":{"system":"sec-edgar","filing":"0001651308-20-000194","document":"wf-form4_160210368555324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000194/wf-form4_160210368555324.xml","form_type":"4"}},{"id":3010560,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-10-07T20:50:09.000Z","date":"2020-10-05","kind":"exercise","acquired":true,"shares":14000,"price":6.5,"value":91000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001651308-20-000194","document":"wf-form4_160210368555324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000194/wf-form4_160210368555324.xml","form_type":"4"}},{"id":3029695,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-16T21:10:06.000Z","date":"2020-09-14","kind":"exercise","acquired":false,"shares":182000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"These securities vest over a four-year period as follows: 25% on July 15, 2016, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon a sale event or certain termination events."}],"balance_after":3613000,"derivative":{"exercise_price":0.5,"expiration_date":"2025-07-01","underlying":"Ordinary Shares","underlying_shares":182000},"source":{"system":"sec-edgar","filing":"0001651308-20-000152","document":"wf-form4_160029059213876.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000152/wf-form4_160029059213876.xml","form_type":"4"}},{"id":3029694,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-09-16T21:10:06.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":103,"price":252.5877,"value":26016.5331,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.51 to $252.59, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-20-000152","document":"wf-form4_160029059213876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000152/wf-form4_160029059213876.xml","form_type":"4"}},{"id":3029693,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-09-16T21:10:06.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":2181,"price":251.954,"value":549511.674,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.47 to $252.42, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":103,"source":{"system":"sec-edgar","filing":"0001651308-20-000152","document":"wf-form4_160029059213876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000152/wf-form4_160029059213876.xml","form_type":"4"}},{"id":3029692,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-09-16T21:10:06.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":3157,"price":250.7063,"value":791479.7891,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.41 to $251.32, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":2284,"source":{"system":"sec-edgar","filing":"0001651308-20-000152","document":"wf-form4_160029059213876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000152/wf-form4_160029059213876.xml","form_type":"4"}},{"id":3029691,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-09-16T21:10:06.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":6478,"price":249.9717,"value":1619316.6726,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.41 to $250.39, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":5441,"source":{"system":"sec-edgar","filing":"0001651308-20-000152","document":"wf-form4_160029059213876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000152/wf-form4_160029059213876.xml","form_type":"4"}},{"id":3029690,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-09-16T21:10:06.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":1681,"price":248.9315,"value":418453.8515,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.41 to $249.36, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":11919,"source":{"system":"sec-edgar","filing":"0001651308-20-000152","document":"wf-form4_160029059213876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000152/wf-form4_160029059213876.xml","form_type":"4"}},{"id":3029689,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-09-16T21:10:06.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":400,"price":247.4625,"value":98985.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.29 to $247.56, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":13600,"source":{"system":"sec-edgar","filing":"0001651308-20-000152","document":"wf-form4_160029059213876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000152/wf-form4_160029059213876.xml","form_type":"4"}},{"id":3029688,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-09-16T21:10:06.000Z","date":"2020-09-14","kind":"exercise","acquired":true,"shares":14000,"price":6.5,"value":91000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001651308-20-000152","document":"wf-form4_160029059213876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000152/wf-form4_160029059213876.xml","form_type":"4"}},{"id":3094827,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-07-01T20:38:32.000Z","date":"2020-06-29","kind":"sale","acquired":false,"shares":300,"price":191.2267,"value":57368.01,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 26, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a sale event."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.00 to $191.34, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-20-000088","document":"wf-form4_159363579383420.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000088/wf-form4_159363579383420.xml","form_type":"4"}},{"id":3103879,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2020-06-19T20:11:41.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":315341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These securities vest over a four-year period as follows: 25% on June 17, 2021, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a sale event."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."}],"balance_after":315341,"derivative":{"exercise_price":13.42,"expiration_date":"2030-06-16","underlying":"Ordinary Shares","underlying_shares":315341},"source":{"system":"sec-edgar","filing":"0001651308-20-000075","document":"wf-form4_159259745253027.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000075/wf-form4_159259745253027.xml","form_type":"4"}},{"id":3103878,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Ordinary Shares","published_at":"2020-06-19T20:11:41.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":55887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 17, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon a sale event."}],"balance_after":172315,"source":{"system":"sec-edgar","filing":"0001651308-20-000075","document":"wf-form4_159259745253027.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000075/wf-form4_159259745253027.xml","form_type":"4"}},{"id":3114264,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2020-06-10T21:17:06.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":453,"price":170.84,"value":77390.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon a sale event."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-20-000067","document":"wf-form4_159182380964210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000067/wf-form4_159182380964210.xml","form_type":"4"}},{"id":3363794,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-21T00:20:41.000Z","date":"2019-11-18","kind":"exercise","acquired":false,"shares":325000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"These securities vest over a four-year period as follows: 25% on July 15, 2016, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon a sale event or certain termination events."}],"balance_after":3795000,"derivative":{"exercise_price":0.5,"expiration_date":"2025-07-01","underlying":"Ordinary Shares","underlying_shares":325000},"source":{"system":"sec-edgar","filing":"0001651308-19-000119","document":"wf-form4_157429562436934.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000119/wf-form4_157429562436934.xml","form_type":"4"}},{"id":3363793,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2019-11-21T00:20:41.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":400,"price":198.93,"value":79572.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-19-000119","document":"wf-form4_157429562436934.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000119/wf-form4_157429562436934.xml","form_type":"4"}},{"id":3363792,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2019-11-21T00:20:41.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":200,"price":197.55,"value":39510.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001651308-19-000119","document":"wf-form4_157429562436934.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000119/wf-form4_157429562436934.xml","form_type":"4"}},{"id":3363791,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2019-11-21T00:20:41.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":200,"price":196.63,"value":39326.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.22 to $197.04, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price."}],"balance_after":600,"source":{"system":"sec-edgar","filing":"0001651308-19-000119","document":"wf-form4_157429562436934.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000119/wf-form4_157429562436934.xml","form_type":"4"}},{"id":3363790,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2019-11-21T00:20:41.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":5633,"price":195.5745,"value":1101671.1585,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.14 to $196.12, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price."}],"balance_after":800,"source":{"system":"sec-edgar","filing":"0001651308-19-000119","document":"wf-form4_157429562436934.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000119/wf-form4_157429562436934.xml","form_type":"4"}},{"id":3363789,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2019-11-21T00:20:41.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":8156,"price":194.6188,"value":1587310.9328,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.13 to $195.09, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price."}],"balance_after":6433,"source":{"system":"sec-edgar","filing":"0001651308-19-000119","document":"wf-form4_157429562436934.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000119/wf-form4_157429562436934.xml","form_type":"4"}},{"id":3363788,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2019-11-21T00:20:41.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":6944,"price":193.5965,"value":1344334.096,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.12 to $194.09, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price."}],"balance_after":14589,"source":{"system":"sec-edgar","filing":"0001651308-19-000119","document":"wf-form4_157429562436934.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000119/wf-form4_157429562436934.xml","form_type":"4"}},{"id":3363787,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2019-11-21T00:20:41.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":2311,"price":192.6301,"value":445168.1611,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.12 to $193.01, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price."}],"balance_after":21533,"source":{"system":"sec-edgar","filing":"0001651308-19-000119","document":"wf-form4_157429562436934.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000119/wf-form4_157429562436934.xml","form_type":"4"}},{"id":3363786,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2019-11-21T00:20:41.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":1156,"price":191.8025,"value":221723.69,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.09 to $192.03, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price."}],"balance_after":23844,"source":{"system":"sec-edgar","filing":"0001651308-19-000119","document":"wf-form4_157429562436934.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000119/wf-form4_157429562436934.xml","form_type":"4"}},{"id":3363785,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2019-11-21T00:20:41.000Z","date":"2019-11-18","kind":"exercise","acquired":true,"shares":25000,"price":6.5,"value":162500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001651308-19-000119","document":"wf-form4_157429562436934.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000119/wf-form4_157429562436934.xml","form_type":"4"}},{"id":3474284,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Ordinary Shares","published_at":"2019-07-02T00:28:48.000Z","date":"2019-06-27","kind":"sale","acquired":false,"shares":5876,"price":9.4712,"value":55652.7712,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price per ordinary share. One ordinary share equals 1/13 American Depositary Share. These shares were sold in multiple transactions at prices ranging from $9.188 to $9.5269, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price."}],"balance_after":122317,"source":{"system":"sec-edgar","filing":"0001651308-19-000071","document":"wf-form4_156202731319451.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000071/wf-form4_156202731319451.xml","form_type":"4"}},{"id":3496636,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2019-06-07T20:15:49.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":558285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a sale event."}],"balance_after":558285,"derivative":{"exercise_price":9.23,"expiration_date":"2029-06-04","underlying":"Ordinary Shares","underlying_shares":558285},"source":{"system":"sec-edgar","filing":"0001651308-19-000059","document":"wf-form4_155993853416435.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000059/wf-form4_155993853416435.xml","form_type":"4"}},{"id":3496635,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Ordinary Shares","published_at":"2019-06-07T20:15:49.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":75855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon a sale event."}],"balance_after":128193,"source":{"system":"sec-edgar","filing":"0001651308-19-000059","document":"wf-form4_155993853416435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000059/wf-form4_155993853416435.xml","form_type":"4"}},{"id":3514618,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2019-05-22T23:03:21.000Z","date":"2019-05-21","kind":"exercise","acquired":true,"shares":301600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These securities vest over a four-year period as follows: 25% on July 15, 2016, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon a sale event or certain termination events."}],"balance_after":4120000,"derivative":{"exercise_price":0.5,"expiration_date":"2025-07-01","underlying":"Ordinary Shares","underlying_shares":301600},"source":{"system":"sec-edgar","filing":"0001651308-19-000047","document":"wf-form4_155856618554356.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000047/wf-form4_155856618554356.xml","form_type":"4"}},{"id":3514617,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2019-05-22T23:03:21.000Z","date":"2019-05-21","kind":"sale","acquired":false,"shares":23200,"price":130.2095,"value":3020860.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.00 to $130.79, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-19-000047","document":"wf-form4_155856618554356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000047/wf-form4_155856618554356.xml","form_type":"4"}},{"id":3514616,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2019-05-22T23:03:21.000Z","date":"2019-05-21","kind":"exercise","acquired":true,"shares":23200,"price":6.5,"value":150800.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."}],"balance_after":23200,"source":{"system":"sec-edgar","filing":"0001651308-19-000047","document":"wf-form4_155856618554356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000047/wf-form4_155856618554356.xml","form_type":"4"}},{"id":3534787,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2019-05-08T21:53:47.000Z","date":"2019-05-06","kind":"exercise","acquired":true,"shares":23400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These securities vest over a four-year period as follows: 25% on July 15, 2016, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon a sale event or certain termination events."}],"balance_after":4421600,"derivative":{"exercise_price":0.5,"expiration_date":"2025-07-01","underlying":"Ordinary Shares","underlying_shares":23400},"source":{"system":"sec-edgar","filing":"0001651308-19-000038","document":"wf-form4_155735241187265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000038/wf-form4_155735241187265.xml","form_type":"4"}},{"id":3534786,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2019-05-08T21:53:47.000Z","date":"2019-05-06","kind":"sale","acquired":false,"shares":1800,"price":130.0078,"value":234014.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.00 to $130.0550, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-19-000038","document":"wf-form4_155735241187265.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000038/wf-form4_155735241187265.xml","form_type":"4"}},{"id":3534785,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2019-05-08T21:53:47.000Z","date":"2019-05-06","kind":"exercise","acquired":true,"shares":1800,"price":6.5,"value":11700.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."}],"balance_after":1800,"source":{"system":"sec-edgar","filing":"0001651308-19-000038","document":"wf-form4_155735241187265.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130819000038/wf-form4_155735241187265.xml","form_type":"4"}},{"id":3881466,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2018-06-28T23:43:37.000Z","date":"2018-06-26","kind":"grant","acquired":true,"shares":364208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These securities vest over a four-year period as follows: 25% on June 26, 2019, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a sale event."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."}],"balance_after":364208,"derivative":{"exercise_price":12.34,"expiration_date":"2028-06-25","underlying":"Ordinary Shares","underlying_shares":364208},"source":{"system":"sec-edgar","filing":"0001179110-18-009114","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018009114/edgar.xml","form_type":"4"}},{"id":3881465,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Ordinary Shares","published_at":"2018-06-28T23:43:37.000Z","date":"2018-06-26","kind":"grant","acquired":true,"shares":52338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 26, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a sale event."}],"balance_after":52338,"source":{"system":"sec-edgar","filing":"0001179110-18-009114","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018009114/edgar.xml","form_type":"4"}},{"id":3987788,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2018-03-20T21:02:21.000Z","date":"2018-03-19","kind":"exercise","acquired":false,"shares":313664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F14","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"These securities vest over a four-year period as follows: 25% on July 15, 2016, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon a sale event or certain termination events."}],"balance_after":4445000,"derivative":{"exercise_price":0.5,"expiration_date":"2025-07-01","underlying":"Ordinary Shares","underlying_shares":313664},"source":{"system":"sec-edgar","filing":"0001179110-18-004691","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018004691/edgar.xml","form_type":"4"}},{"id":3987787,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-20T21:02:21.000Z","date":"2018-03-16","kind":"exercise","acquired":false,"shares":141336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F14","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"These securities vest over a four-year period as follows: 25% on July 15, 2016, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon a sale event or certain termination events."}],"balance_after":4758664,"derivative":{"exercise_price":0.5,"expiration_date":"2025-07-01","underlying":"Ordinary Shares","underlying_shares":141336},"source":{"system":"sec-edgar","filing":"0001179110-18-004691","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018004691/edgar.xml","form_type":"4"}},{"id":3987786,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2018-03-20T21:02:21.000Z","date":"2018-03-19","kind":"sale","acquired":false,"shares":900,"price":164.3589,"value":147923.01,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.16 to $165.03, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-004691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018004691/edgar.xml","form_type":"4"}},{"id":3987785,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2018-03-20T21:02:21.000Z","date":"2018-03-19","kind":"sale","acquired":false,"shares":4636,"price":163.4818,"value":757901.6248,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.16 to $164.15, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price."}],"balance_after":900,"source":{"system":"sec-edgar","filing":"0001179110-18-004691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018004691/edgar.xml","form_type":"4"}},{"id":3987784,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2018-03-20T21:02:21.000Z","date":"2018-03-19","kind":"sale","acquired":false,"shares":5133,"price":162.7864,"value":835582.5912,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.15 to $163.13, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price."}],"balance_after":5536,"source":{"system":"sec-edgar","filing":"0001179110-18-004691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018004691/edgar.xml","form_type":"4"}},{"id":3987783,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2018-03-20T21:02:21.000Z","date":"2018-03-19","kind":"sale","acquired":false,"shares":3141,"price":161.6239,"value":507660.6699,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.13 to $162.05, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price."}],"balance_after":10669,"source":{"system":"sec-edgar","filing":"0001179110-18-004691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018004691/edgar.xml","form_type":"4"}},{"id":3987782,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2018-03-20T21:02:21.000Z","date":"2018-03-19","kind":"sale","acquired":false,"shares":9618,"price":160.6001,"value":1544651.7618,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.07 to $161.05, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price."}],"balance_after":13810,"source":{"system":"sec-edgar","filing":"0001179110-18-004691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018004691/edgar.xml","form_type":"4"}},{"id":3987781,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2018-03-20T21:02:21.000Z","date":"2018-03-19","kind":"sale","acquired":false,"shares":5200,"price":159.6234,"value":830041.68,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.06 to $160.05, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price."}],"balance_after":23428,"source":{"system":"sec-edgar","filing":"0001179110-18-004691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018004691/edgar.xml","form_type":"4"}},{"id":3987780,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2018-03-20T21:02:21.000Z","date":"2018-03-19","kind":"sale","acquired":false,"shares":500,"price":158.448,"value":79224.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.04 to $158.86, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price."}],"balance_after":28628,"source":{"system":"sec-edgar","filing":"0001179110-18-004691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018004691/edgar.xml","form_type":"4"}},{"id":3987779,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2018-03-20T21:02:21.000Z","date":"2018-03-19","kind":"exercise","acquired":true,"shares":24128,"price":6.5,"value":156832.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price is represented in ADSs."}],"balance_after":29128,"source":{"system":"sec-edgar","filing":"0001179110-18-004691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018004691/edgar.xml","form_type":"4"}},{"id":3987778,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"Amerian Depositary Shares","published_at":"2018-03-20T21:02:21.000Z","date":"2018-03-16","kind":"sale","acquired":false,"shares":400,"price":157.9775,"value":63191.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.97 to $157.98, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001179110-18-004691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018004691/edgar.xml","form_type":"4"}},{"id":3987777,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2018-03-20T21:02:21.000Z","date":"2018-03-16","kind":"sale","acquired":false,"shares":7264,"price":157.4105,"value":1143429.872,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.95 to $157.93, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price."}],"balance_after":5400,"source":{"system":"sec-edgar","filing":"0001179110-18-004691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018004691/edgar.xml","form_type":"4"}},{"id":3987776,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2018-03-20T21:02:21.000Z","date":"2018-03-16","kind":"sale","acquired":false,"shares":2208,"price":156.7458,"value":346094.7264,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.95 to $156.94, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price."}],"balance_after":12664,"source":{"system":"sec-edgar","filing":"0001179110-18-004691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018004691/edgar.xml","form_type":"4"}},{"id":3987775,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2018-03-20T21:02:21.000Z","date":"2018-03-16","kind":"sale","acquired":false,"shares":1000,"price":154.95,"value":154950.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":14872,"source":{"system":"sec-edgar","filing":"0001179110-18-004691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018004691/edgar.xml","form_type":"4"}},{"id":3987774,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Strategy Officer"}}],"security":"American Depositary Shares","published_at":"2018-03-20T21:02:21.000Z","date":"2018-03-16","kind":"exercise","acquired":true,"shares":10872,"price":6.5,"value":70668.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price is represented in ADSs."}],"balance_after":15872,"source":{"system":"sec-edgar","filing":"0001179110-18-004691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018004691/edgar.xml","form_type":"4"}},{"id":4270267,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CSO"}}],"security":"Share Option (Right to Buy)","published_at":"2017-06-30T00:05:34.000Z","date":"2017-06-29","kind":"grant","acquired":true,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest over a four-year period as follows: 25% on the first anniversary of the date of grant, with the remaining shares vesting in 36 equal successive monthly installments on the last day of each month thereafter. Unvested options are subject to accelerated vesting upon a sale event."}],"balance_after":1250000,"derivative":{"exercise_price":3.46,"expiration_date":"2027-06-29","underlying":"Ordinary Shares","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0001179110-17-009800","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911017009800/edgar.xml","form_type":"4/A","original_submission_date":"2017-06-29"}},{"id":4270265,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CSO"}}],"security":"Share Option (Right to Buy)","published_at":"2017-06-29T22:59:47.000Z","date":"2017-06-29","kind":"grant","acquired":true,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest over a four-year period as follows: 25% on the first anniversary of the date of grant, with the remaining shares vesting in 36 equal successive monthly installments on the last day of each month thereafter. Unvested options are subject to accelerated vesting upon a sale event."}],"balance_after":1250000,"derivative":{"exercise_price":3.46,"expiration_date":"2027-06-29","underlying":"Ordinary Shares","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0001179110-17-009796","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911017009796/edgar.xml","form_type":"4"}},{"id":4548953,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":137732,"kind":"person","name":"Liang Howard","position":1,"cik":"0001663427","reported_name":"Liang Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CSO"}}],"security":"Share Option (Right to Buy)","published_at":"2016-11-18T21:11:58.000Z","date":"2016-11-16","kind":"grant","acquired":true,"shares":1752500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"In ordinary shares.  One American Depositary Share represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"In ordinary shares.  One American Depositary Share represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities vest over a four-year period as follows:  25% on July 13, 2017, and the remaining in 36 successive equal monthly installments, subject to continued service.  All unvested shares subject to this option are subject to accelerated vesting upon a sale event."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"In ordinary shares.  One American Depositary Share represents 13 ordinary shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In ordinary shares.  One American Depositary Share represents 13 ordinary shares."}],"balance_after":1752500,"derivative":{"exercise_price":2.84,"expiration_date":"2026-11-15","underlying":"Ordinary shares","underlying_shares":1752500},"source":{"system":"sec-edgar","filing":"0001179110-16-031842","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911016031842/edgar.xml","form_type":"4"}}]}